SAN DIEGO, March 5 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced the relocation of the Company's corporate headquarters and research laboratories to San Diego. The new facility will be in the Sorrento Valley and will house the Company's research, preclinical and clinical development, pharmaceutical sciences and administrative operations.
"Moving our two southern California facilities to San Diego's biotechnology corridor is integral to our future growth and success, uniting the organization while providing access to a wealth of biotechnology and pharmaceutical industry expertise," said Barry D. Quart, PharmD, Ardea Biosciences' President and CEO. "We look forward to becoming an important contributor to the San Diego community at large."
Employees from both southern California locations will be relocating to
our new facility and additional career opportunities can be found on the
"Careers" page of the Company's website at http://www.ardeabio.com. For
additional career related information please email firstname.lastname@example.org.
New Contact Information as of March 4, 2008:
Ardea Biosciences, Inc.
4939 Directors Place
San Diego, CA 92121
About Ardea Biosciences, Inc.
Ardea Biosciences of San Diego, California is a biotechnology company
focused on the discovery and development of small-molecule therapeutics in
virology, oncology and inflammation. The Company has two product candidates
in clinical development and several others in preclinical development.
Ardea's most advanced clinical deve
|SOURCE Ardea Biosciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved